Impact of Preoperative Factors in Patients with Inflammatory Bowel Disease (IBD) on Length of Stay: An IBD-NSQIP Collaborative Analysis

Inflammatory bowel disease (IBD) patients are challenging to manage perioperatively due to disease complexity and multiple comorbidities. This retrospective multicenter database study aims to assess factors associated with extended length of stay in post-surgical IBD patients.
Source: Journal of the American College of Surgeons - Category: Surgery Authors: Tags: Colon and Rectal Surgery Source Type: research

Related Links:

Lab Chip, 2021, Advance Article DOI: 10.1039/D1LC00451D, PaperSina Nejati, Jiangshan Wang, Ulisses Heredia-Rivera, Sotoudeh Sedaghat, Ian Woodhouse, Jay S. Johnson, Mohit Verma, Rahim Rahimi A non-invasive sampling capsule is introduced to site-selectively collect calprotectin biomarker from the small intestine. This approach can be accompanied with the fecal calprotectin assay to diagnose IBD and differentiate its types (CD and UC). To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Lab Chip latest articles - Category: Chemistry Authors: Source Type: research
In this study, we described a unique case of cutaneous metaplasia on the elbow of a 25-year-old man who had a clinical history of epidermolysis bullosa simplex, but had no history of any gastrointestinal disease. The lesion had been clinically stable for 5 years. Histopathologically, the epithelium showed many columnar cells with mucinous cytoplasm, with no atypia or mitoses. The proliferation rate was low (7% by Ki67). The metaplastic areas expressed epithelial membrane antigen, carcinoembryonic antigen, cytokeratin 7, MUC5AC, MUC2, and Cyclin-D1.
Source: The American Journal of Dermatopathology - Category: Pathology Tags: Extraordinary Case Report Source Type: research
This holiday season, we are all in search of the perfect gift. What is the one thing you truly desire for yourself and your family? Don’t you think we all want it? What if you were handed a beautifully wrapped box containing a miraculous tool that caused dramatic weight loss and good health without limiting calories or requiring exercise? What if this gift reduced appetite, shrunk belly fat, and dropped your dress size? What if that same gift freed you from acid reflux, heartburn, bowel urgency, and diarrhea, but also improved mood, increased energy, deepened sleep, and reduced or eliminated joint pain? And all of th...
Source: Wheat Belly Blog - Category: Cardiology Authors: Tags: Open Source Type: blogs
Singapore Med J. 2021 Nov 26. doi: 10.11622/smedj.2021173. Online ahead of print.ABSTRACTThe landscape of ulcerative colitis has changed in the last two decades. Advancements in pharmacotherapeutics have heralded the introduction of new treatment options, with many agents in development. Better clinical outcomes are seen with tighter disease control, made possible with greater understanding of inflammatory pathways and their blockade with drugs. There has been a resultant shift in treatment targets, beyond symptoms to endoscopic and histological healing. Controlling the burden of disease activity also lowers the risk of de...
Source: Singapore Medical Journal - Category: General Medicine Authors: Source Type: research
Locum - Physician - Gastroenterologist Pittsfield, MA This will be an ongoing assignment Patient Volume: 5-10 consults per day, 5-10 procedures per day (during the week). A few patients and occasional procedures on weekends. Travel/lodging is reimbursable We provide treatment for all digestive diseases and conditions including: • Digestive tract bleeding • Celiac disease • Colitis • Colon polyps • Crohns • Incontinence • Gallstones • Hemochromatosis • Hepatitis • Irritable Bowel... Read more
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Gastroenterology Source Type: forums
Crohn's disease (CD) patients included in the TAILORIX trial started infliximab in combination with an immunosuppressant for one year. The aim of the present study was to determine the long-term disease course beyond the study period.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Source Type: research
Z Gastroenterol. 2021 Nov 24. doi: 10.1055/a-1672-4861. Online ahead of print.ABSTRACTInflammatory bowel diseases have recorded increasing incidence. A long period of illness and immunsuppressive drugs run a high risk of complications, this is particularly true for neoplasias.Medical records of patients with inflammatory bowel diseases who developed a malignant disease during 2000 and 2020 were used for analysis.51 patients could be included. 56% of tumors were located extraintestinal and occurred more often in patient with Crohn's disease. Neoplasias were more frequent in men (61 %).Individual prevention recommendations a...
Source: Zeitschrift fur Gastroenterologie - Category: Gastroenterology Authors: Source Type: research
Rev Esp Enferm Dig. 2021 Nov 25. doi: 10.17235/reed.2021.8457/2021. Online ahead of print.ABSTRACTCrohn's disease of the reservoir is a pathology of difficult diagnosis and complex approach due to the scarce documented evidence on it. Recently, studies have been published on the treatment strategies available for this entity. Based on the above, we have analyzed the experience of our center in the treatment of reservoir Crohn's disease with one of the new biologic agents, ustekinumab.PMID:34818897 | DOI:10.17235/reed.2021.8457/2021
Source: Revista Espanola de Enfermedades Digestivas - Category: Gastroenterology Authors: Source Type: research
CONCLUSION: The rate of MEFV gene mutations was high in patients with UC who required surgery. These patients have frequent and severe attacks, indicating that the mutations are related to disease severity. MEFV mutation as a modifier factor of IBD should be considered.PMID:34819953 | PMC:PMC8608532 | DOI:10.1155/2021/5538150
Source: Gastroenterology Research and Practice - Category: Gastroenterology Authors: Source Type: research
Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, are chronic, relapsing intestinal inflammatory disorders. Although the molecular mechanisms governing the pathogenesis of IBD are not completely clear, the main factors are presumed to be a complex interaction between genetic predisposition, host immune response and environmental exposure, especially the intestinal microbiome. Currently, most studies have focused on the role of gut bacteria in the onset and development of IBD, whereas little attention has been paid to the enteroviruses. Among of them, viruses that infect prokaryotes, ...
Source: Frontiers in cellular and infection microbiology - Category: Microbiology Source Type: research
More News: Databases & Libraries | Inflammatory Bowel Disease | Study | Surgery | Valerian